Cathie's Ark Logo
undefined Logo

ARKG Holdings of Vertex Pharmaceuticals (VRTX) - Updated Daily

TherapeuticsGene TherapyGenomicsCRSPR Gene Editing
Date
Direction
Shares
Fund Weight
Fund
August 8, 2024
SELL5.454k0.2019%ARKG
May 30, 2024
SELL4.641k0.1502%ARKG
May 28, 2024
SELL6.238k0.1978%ARKG
March 25, 2024
SELL1.133k0.0295%ARKG
March 21, 2024
SELL6.711k0.171%ARKG

Key Statistics

⚖️Weighting🧢Market Cap
2.38%$120.79b
🏋🏿‍♂️Weight Rank In ARKG🌏Country
6🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
155$225.49
🎫ARK Ownership Percent
0.03%

Other ETFs That Hold VRTX

Ticker
NameWeight
IBBiShares Biotechnology ETF7.42%
GNOMGlobal X Genomics & Biotechnology ETF2.17%
ARKGARK Genomic Revolution ETF1.98%
XLVHealth Care Select Sector SPDR® Fund1.68%
XBISPDR® S&P Biotech ETF1.09%
QYLDGlobal X NASDAQ 100 Covered Call ETF0.66%
QQQInvesco QQQ Trust0.64%
SPYSPDR S&P 500 ETF Trust0.24%
LABUS&P Biotech Bull 3X Shares ETF0.238%

Research Notes and Commentary for VRTX

No Research Notes Found for VRTX